Bayar M Najat Nakishbandy1, Sabat A M Barawi2. 1. Senior registrar, Maternity Teaching Hospital/ Erbil, Iraq. 2. Assist, Professor and head of Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil, Iraq.
Abstract
BACKGROUND AND OBJECTIVES: high concentrations of maternal C-reactive protein have been associated with adverse pregnancy outcome, and premature uterine contraction may be predicted by elevated levels of C-reactive protein. This may ultimately be simple and cost-effective enough to introduce as a low-risk screening program. PATIENTS AND METHODS: an observational case control study was performed from May 1st, 2010 to December 1st, 2010 at Maternity Teaching Hospital-Erbil/ Kurdistan Region/ Iraq. The sample size was (200) cases. Hundred of them were presented with premature uterine contractions at 24(+0)-36(+6) weeks. The other hundred were control group at same gestational ages. The level of C-reactive protein was determined in both groups and both groups were followed till delivery. RESULTS: (93) out of (100) women with premature uterine contractions had elevated level of C-Reactive protein and 91% delivered prematurely while in the control group only (9) out of (100) women had elevated level of C-reactive protein and only 8% of them delivered preterm. Differences were statistically highly significant. CONCLUSION: C-reactive protein can be used as a biomarker in prediction of premature delivery when it is associated with premature uterine contractions. As well it can be used as a screening test to detect cases that are at risk of premature delivery.
BACKGROUND AND OBJECTIVES: high concentrations of maternal C-reactive protein have been associated with adverse pregnancy outcome, and premature uterine contraction may be predicted by elevated levels of C-reactive protein. This may ultimately be simple and cost-effective enough to introduce as a low-risk screening program. PATIENTS AND METHODS: an observational case control study was performed from May 1st, 2010 to December 1st, 2010 at Maternity Teaching Hospital-Erbil/ Kurdistan Region/ Iraq. The sample size was (200) cases. Hundred of them were presented with premature uterine contractions at 24(+0)-36(+6) weeks. The other hundred were control group at same gestational ages. The level of C-reactive protein was determined in both groups and both groups were followed till delivery. RESULTS: (93) out of (100) women with premature uterine contractions had elevated level of C-Reactive protein and 91% delivered prematurely while in the control group only (9) out of (100) women had elevated level of C-reactive protein and only 8% of them delivered preterm. Differences were statistically highly significant. CONCLUSION:C-reactive protein can be used as a biomarker in prediction of premature delivery when it is associated with premature uterine contractions. As well it can be used as a screening test to detect cases that are at risk of premature delivery.
Authors: Hope M Cottrill; John R Barton; John M O'brien; Debbie L Rhea; Douglas A Milligan Journal: Am J Obstet Gynecol Date: 2004-05 Impact factor: 8.661
Authors: S H Yap; H J Moshage; B P Hazenberg; H M Roelofs; J Bijzet; P C Limburg; L A Aarden; M H van Rijswijk Journal: Biochim Biophys Acta Date: 1991-02-19
Authors: Morgan R Peltier; David S Faux; Steven D Hamblin; Robert M Silver; M Sean Esplin Journal: J Reprod Immunol Date: 2009-12-14 Impact factor: 4.054
Authors: Danilo Dias Santana; Gilberto Kac; Pedro Paulo Teixeira Dos Santos; Thainá Castro da Silva; Camila Benaim; Paula Guedes Cocate; Maria Beatriz Trindade de Castro; Berit Lilienthal Heitmann; Amanda Rodrigues Amorim Adegboye Journal: Int J Environ Res Public Health Date: 2022-02-25 Impact factor: 3.390